Cloud DX Reports FY2023 Results
Highlights include 55.4% increase in total revenue, 69% increase in subscription revenue, 112.8% increase in gross profit, and 20.4% reduction...
Year: 2024
IRLAB publishes Annual Report for 2023
GOTHENBURG, SWEDEN / ACCESSWIRE / April 29, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA), a company discovering and developing novel treatments for...
HD Nursing Honored as Silver Stevie® Award Winner in 2024 American Business Awards®
BENTON, Ark.--(BUSINESS WIRE)--HD Nursing, the leading patient safety solution that combines predictive analytics with individualized fall and pressure injury prevention,...
Dr. David Rhew, Global Chief Medical Officer & Vice President of Healthcare at Microsoft, to Address Rural and Community Healthcare Professionals at TruBridge National Client Conference
TruBridge Brings the Needs of Rural and Community Health to the Forefront in Collaboration with MicrosoftMOBILE, Ala.--(BUSINESS WIRE)--TruBridge, Inc. (NASDAQ:...
“Seeing the Invisible”: New Tech Enables Deep Tissue Imaging During Surgery
Researchers have developed a novel rigid endoscope system for visible-to-over-thousand-nanometer hyperspectral imaging for advanced medical procedures Hyperspectral imaging (HSI) is...
Sona’s Cancer Therapy Creates a Systemic Immune Response in Murine Breast Cancer Model
Halifax, Nova Scotia--(Newsfile Corp. - April 29, 2024) - Sona Nanotech Inc. (CSE: SONA) (OTCQB: SNANF) (the "Company" or "Sona")...
GE HealthCare Receives FDA Clearance for Portrait VSM, Building on Its Growing Ecosystem of Connected Patient Monitoring Solutions
The portable vital signs monitor (VSM) adds to GE HealthCare’s growing Portrait Ecosystem to help clinicians make timely treatment decisions...
Cardio Diagnostics Announces Publication of Study Showing That its PrecisionCHD™ Test Could Save Health Insurers Over $113 Million Annually
The Peer-Reviewed Publication Demonstrates the Potential Economic Benefits of the PrecisionCHD™ Test for the Detection and Management of Coronary Heart...
Community Impact: Unite Iowa Adds 12,500 Programs to Unite Us Platform to Increase Access to Vital Community Resources
The state's leading coordinated care network, operated by CyncHealth Iowa, celebrates a milestone year serving Iowa residents using Unite Us'...
Serve You Rx Named a Top Workplace for 2024
Pharmacy Benefit Manager Prioritizes Flexibility and Work-Life Balance for Its EmployeesMILWAUKEE, WI / ACCESSWIRE / April 29, 2024 / Serve...
Nava Health Continues Expansion With Opening Of New Location in Plantation, Florida
Second South Florida Location Strengthens Southern Presence COLUMBIA, MD / ACCESSWIRE / April 29, 2024 / Nava Health, a leader...
Napo Pharmaceuticals, a Jaguar Health Family Company, Sponsoring Pediatric Gastroenterology Conference in Abu Dhabi and Panel Discussion About Microvillus Inclusion Disease (MVID)
Jaguar's novel plant-based prescription drug crofelemer has been granted Orphan Drug Designation by the FDA and the European Medicines Agency...
FREmedica Partners With CellCore at ECO24
VANCOUVER, BC / ACCESSWIRE / April 29, 2024 / Frequency Exchange Corp. ("Frequency Exchange" or the "Company") (TSXV:FREQ) is excited...
Hypha Labs Names Craig Ellins Chief Science Officer
LAS VEGAS, NV / ACCESSWIRE / April 29, 2024 / Hypha Labs, Inc. (OTC Pink:DIGP) has announced that it has...
Specialty Revenue Cycle Management Firms Revolutionize Complex Claims Processing Through Automation, Garnering Rapid Adoption Among Providers, Black Book Survey
Black Book surveyed nearly 5,000 healthcare providers in a sweeping study of the evolving revenue cycle management IT sector. EnableComp...
Planet 13 Announces OMMU Approval for Proposed Sale of Planet 13 Florida and Acquisition of VidaCann
LAS VEGAS, NV / ACCESSWIRE / April 29, 2024 / Planet 13 Holdings Inc. (CSE:PLTH)(OTCQX:PLNH) ("Planet 13" or the "Company"),...
AIM ImmunoTech Announces First Dose Level is Generally Well-Tolerated in Phase 1b/2 Study of Ampligen and Imfinzi as a Combination Therapy for Late-Stage Pancreatic Cancer
Next safety cohort to begin escalated dosing soonOCALA, Fla., April 29, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American:...
Harvard Bioscience Schedules First Quarter 2024 Earnings Conference Call for May 7, 2024 at 8:00 AM ET
HOLLISTON, Mass., April 29, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the...
SELLAS Life Sciences Announces Positive Recommendation of Independent Data Monitoring Committee Following Completion of Enrollment in REGAL Phase 3 Study
– Based on the Efficacy and Safety Data Assessed, the Independent Data Monitoring Committee (IDMC) Recommends Continuation of Phase 3...
GRI Bio Announces Abstracts Accepted for Presentation at the 14th International Congress on Autoimmunity
LA JOLLA, CA, April 29, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a...